Sirolimus-eluting stents achieved zero restenosis in first-in-man results, and paclitaxel-eluting stents subsequently demonstrated the capability to decrease restenosis.
The introduction of sirolimus- and paclitaxel-eluting stents represented a major breakthrough in interventional cardiology by effectively preventing restenosis.
Absolute Event Rate: 0% vs 0%
The publication in January 2001 of the first-in-man results showing zero restenosis after sirolimus-eluting stent implantation produced enormous excitement in the cardiological community. The long-awaited tool—a safe, restenosis-proof, easy-to-use stent— had been found. It was not too long thereafter that paclitaxel-eluting stents also demonstrated their capability to decrease restenosis.
Lemos et al. (Mon,) reported a other. Sirolimus-eluting stents achieved zero restenosis in first-in-man results, and paclitaxel-eluting stents subsequently demonstrated the capability to decrease restenosis.